NCI, Inc. (NCIT) Receives $18.33 Consensus Price Target from Analysts
Shares of NCI, Inc. (NASDAQ:NCIT) have been assigned an average rating of “Hold” from the six brokerages that are covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year target price among brokers that have covered the stock in the last year is $18.33.
A number of research firms have recently commented on NCIT. Zacks Investment Research cut NCI from a “hold” rating to a “sell” rating in a research report on Saturday, April 8th. FBR & Co restated a “hold” rating and issued a $11.00 price target on shares of NCI in a research report on Tuesday, April 4th. Cowen and Company restated a “buy” rating and issued a $24.00 price target on shares of NCI in a research report on Monday, July 3rd. Noble Financial restated a “buy” rating on shares of NCI in a research report on Friday, May 12th. Finally, SunTrust Banks, Inc. cut NCI from a “buy” rating to a “hold” rating and dropped their price target for the company from $24.00 to $20.00 in a research report on Monday, July 3rd.
COPYRIGHT VIOLATION WARNING: This article was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/07/24/nci-inc-ncit-receives-18-33-consensus-price-target-from-analysts.html.
A number of institutional investors have recently added to or reduced their stakes in NCIT. Royce & Associates LP purchased a new stake in shares of NCI during the first quarter valued at approximately $7,663,000. Goldman Sachs Group Inc. purchased a new stake in shares of NCI during the first quarter valued at approximately $432,000. Renaissance Technologies LLC raised its stake in shares of NCI by 5.2% in the first quarter. Renaissance Technologies LLC now owns 404,799 shares of the information technology services provider’s stock valued at $6,092,000 after buying an additional 20,074 shares during the period. Russell Investments Group Ltd. purchased a new stake in shares of NCI during the fourth quarter valued at approximately $216,000. Finally, Hancock Holding Co. purchased a new stake in shares of NCI during the first quarter valued at approximately $189,000. Institutional investors own 39.04% of the company’s stock.
NCI (NCIT) traded down 0.25% during trading on Friday, reaching $19.90. The company had a trading volume of 101,062 shares. The company’s 50-day moving average is $20.18 and its 200 day moving average is $16.03. The firm has a market capitalization of $269.66 million, a price-to-earnings ratio of 44.52 and a beta of 1.04. NCI has a 52 week low of $10.98 and a 52 week high of $21.40.
NCI (NASDAQ:NCIT) last released its earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.21 by $0.04. The firm had revenue of $78.75 million during the quarter, compared to analyst estimates of $76.55 million. NCI had a return on equity of 11.73% and a net margin of 2.13%. Equities analysts anticipate that NCI will post $1.00 EPS for the current year.
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
Receive News & Stock Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related stocks with our FREE daily email newsletter.